|
1
|
Kamangar F, Dores GM and Anderson WF:
Patterns of cancer incidence, mortality, and prevalence across five
continents: Defining priorities to reduce cancer disparities in
different geographic regions of the world. J Clin Oncol.
24:2137–2150. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ghoncheh M, Pournamdar Z and Salehiniya H:
Incidence and mortality and epidemiology of breast cancer in the
world. Asian Pac J Cancer Prev. 17:43–46. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ataollahi MR, Sharifi J, Paknahad MR and
Paknahad A: Breast cancer and associated factors: A review. J Med
Life. 8:6–11. 2015.PubMed/NCBI
|
|
4
|
Tankard RM, Bennett MF, Degorski P,
Delatycki MB, Lockhart PJ and Bahlo M: Detecting expansions of
tandem repeats in cohorts sequenced with short-read sequencing
data. Am J Hum Genet. 103:858–873. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Medicine N: The future of cancer genomics.
Nat Med. 21:992015. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
International Cancer Genome Consortium,
Hudson TJ, Anderson W, Artez A, Barker AD, Bell C, Bernabé RR, Bhan
MK, Calvo F, Eerola I, et al: International network of cancer
genome projects. Nature. 464:993–998. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets-update. Nucleic Acids Res. 39:D991–D995.
2013.
|
|
8
|
Ong SL, Gravante G, Metcalfe MS and
Dennison AR: History, ethics, advantages and limitations of
experimental models for hepatic ablation. World J Gastroenterol.
19:147–154. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Afshari E, Rostami M and Farahmand F:
Review on different experimental techniques developed for recording
force-deformation behaviour of soft tissues; with a view to surgery
simulation applications. J Med Eng Technol. 41:257–274. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Moldovan L, Mitroi A, Petrescu CM and
Aschie M: Classification of breast carcinomas according to gene
expression profiles. J Med Life. 6:14–17. 2013.PubMed/NCBI
|
|
11
|
Srivastava P, Mangal M and Agarwal SM:
Understanding the transcriptional regulation of cervix cancer using
microarray gene expression data and promoter sequence analysis of a
curated gene set. Gene. 535:233–238. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kandoth C, Mclellan MD, Vandin F, Ye K,
Niu B, Lu C, Xie M, Zhang Q, McMichael JF, Wyczalkowski MA, et al:
Mutational landscape and significance across 12 major cancer types.
Nature. 502:333–339. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guo Y, Bao Y, Ma M and Yang W:
Identification of key candidate genes and pathways in colorectal
cancer by integrated bioinformatical analysis. Int J Mol Sci.
18:E7222017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pan Q, Long X, Song L, Zhao D, Li X, Li D,
Li M, Zhou J, Tang X, Ren H and Ding K: Transcriptome sequencing
identified hub genes for hepatocellular carcinoma by weighted-gene
co-expression analysis. Oncotarget. 7:38487–38499. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yin L, Cai Z, Zhu B and Xu C:
Identification of key pathways and genes in the dynamic progression
of HCC based on WGCNA. Genes. 9:E922018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou Z, Cheng Y, Jiang Y, Liu S, Zhang M,
Liu J and Zhao Q: Ten hub genes associated with progression and
prognosis of pancreatic carcinoma identified by co-expression
analysis. Int J Biol Sci. 14:124–136. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Langfelder P and Horvath S: WGCNA: An R
package for weighted correlation network analysis. BMC
Bioinformatics. 9:5592008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang X, Feng H, Li Z, Li D, Liu S, Huang
H and Li M: Application of weighted gene co-expression network
analysis to identify key modules and hub genes in oral squamous
cell carcinoma tumorigenesis. OncoTargets Ther. 11:6001–6021. 2018.
View Article : Google Scholar
|
|
19
|
Pedraza V, Gomezcapilla JA, Escaramis G,
Gomez C, Torné P, Rivera JM, Gil A, Araque P, Olea N, Estivill X
and Fárez-Vidal ME: Gene expression signatures in breast cancer
distinguish phenotype characteristics, histologic subtypes, and
tumor invasiveness. Cancer. 116:486–496. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Maubant S, Tesson B, Maire V, Ye M,
Rigaill G, Gentien D, Cruzalegui F, Tucker GC, Roman-Roman S and
Dubois T: Transcriptome analysis of Wnt3a-treated triple-negative
breast cancer cells. PLoS One. 10:e01223332015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Smyth GK: limma: Linear models for
microarray data. In: Bioinformatics and Computational Biology
Solutions Using R and Bioconductor. Gentleman R, Carey VJ, Huber W,
Irizarry RA and Dudoit S: Springer; New York, NY: pp. 397–420.
2005
|
|
22
|
R Core Team: A language and environment
for statistical computing R Foundation for Statistical Computing,
Vienna, Austria. https://www.R-project.org/June
16–2014PubMed/NCBI
|
|
23
|
Bland JM and Altman DG: Multiple
significance tests: The Bonferroni method. BMJ. 310:1701995.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene Ontology: Tool for the unification of biology. Nat
Genet. 25:25–29. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yu G, Wang LG, Han Y and He QY:
ClusterProfiler: An R package for comparing biological themes among
gene clusters. OMICS. 16:284–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Szklarczyk D, Morris JH, Cook H, Kuhn M,
Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, et al:
The STRING database in 2017: quality-controlled protein-protein
association networks, made broadly accessible. Nucleic Acids Res.
45:D362–D368. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bader GD and Hogue CW: An automated method
for finding molecular complexes in large protein interaction
networks. BMC Bioinformatics. 4:22003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lánczky A, Nagy Á, Bottai G, Munkácsy G,
Szabó A, Santarpia L and Győrffy B: miRpower: A web-tool to
validate survival-associated miRNAs utilizing expression data from
2178 breast cancer patients. Breast Cancer Res Treat. 160:439–446.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mohr S, Leikauf GD, Keith G and Rihn BH:
Microarrays as cancer keys: An array of possibilities. J Clin
Oncol. 20:3165–3175. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chakravarty D, Gao J, Phillips SM, Kundra
R, Zhang H, Wang J, Rudolph JE, Yaeger R, Soumerai T, Nissan MH, et
al: OncoKB: A precision oncology knowledge base. JCO Precis Oncol.
2017:2017.
|
|
33
|
de Voer RM, Geurts VKA, Weren RD,
Ligtenberg MJ, Smeets D, Fu L, Vreede L, Kamping EJ, Verwiel ET,
Hahn MM, et al: Germline mutations in the spindle assembly
checkpoint genes BUB1 and BUB3 are risk factors for colorectal
cancer. Gastroenterology. 145:544–547. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Takagi K, Miki Y, Shibahara Y, Nakamura Y,
Ebata A, Watanabe M, Ishida T, Sasano H and Suzuki T: BUB1
immunolocalization in breast carcinoma: Its nuclear localization as
a potent prognostic factor of the patients. Horm Cancer. 4:92–102.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xin F, Guo C, Cai ZD, Wang C, Liu ZZ, Lin
ZY, Wu YD, Liang YX, Han ZD, Liu JC and Zhong WD: Overexpression of
BUB1B contributes to progression of prostate cancer and predicts
poor outcome in patients with prostate cancer. Onco Targets Ther.
9:2211–2220. 2016.PubMed/NCBI
|
|
36
|
De MR, Vieira S, Chinen LT, Chiappelli F,
da Fonseca FP, Guimarães GC, Soares FA, Neves I, Pagotty S,
Pellionisz PA, et al: Prognostication of prostate cancer based on
TOP2A protein and gene assessment: TOP2A in prostate cancer. J
Transl Med. 11:362013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Panvichian R, Tantiwetrueangdet A,
Angkathunyakul N and Leelaudomlipi S: TOP2A amplification and
overexpression in hepatocellular carcinoma tissues. Biomed Res Int.
2015:3816022015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sehdev V, Katsha A, Arras J, Peng D,
Soutto M, Ecsedy J, Zaika A, Belkhiri A and El-Rifai W: HDM2
regulation by AURKA promotes cell survival in gastric cancer. Clin
Cancer Res. 20:76–86. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lu L, Han H, Tian Y, Li W, Zhang J, Feng M
and Li Y: Aurora kinase A mediates c-Myc's oncogenic effects in
hepatocellular carcinoma. Mol Carcinog. 54:1467–1479. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xiea Y and Wangb R: Pttg1 promotes growth
of breast cancer through P27 nuclear exclusion. Cell Physiol
Biochem. 38:393–400. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yoon CH, Kim MJ, Lee H, Kim RK, Lim EJ,
Yoo KC, Lee GH, Cui YH, Oh YS, Gye MC, et al: PTTG1 Oncogene
promotes tumor malignancy via epithelial to mesenchymal transition
and expansion of cancer stem cell population. J Biol Chem.
287:19516–19527. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Landry BD, Mapa CE, Arsenault HE, Poti KE
and Benanti JA: Regulation of a transcription factor network by
Cdk1 coordinates late cell cycle gene expression. EMBO J.
33:1044–1060. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang Y, Huang W, Ran Y, Xiong Y, Zhong Z,
Fan X, Wang Z and Ye Q: miR-582-5p inhibits proliferation of
hepatocellular carcinoma by targeting CDK1 and AKT3. Tumor Biol.
36:8309–8316. 2015. View Article : Google Scholar
|
|
44
|
Rawat A, Gopal G, Selvaluxmy G and
Rajkumar T: Inhibition of ubiquitin conjugating enzyme UBE2C
reduces proliferation and sensitizes breast cancer cells to
radiation, doxorubicin, tamoxifen and letrozole. Cell Oncol.
36:459–467. 2013. View Article : Google Scholar
|
|
45
|
Chou CP, Huang NC, Jhuang SJ, Pan HB, Peng
NJ, Cheng JT, Chen CF, Chen JJ and Chang TH: Ubiquitin-conjugating
enzyme UBE2C is highly expressed in breast microcalcification
lesions. PLoS One. 9:e939342014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ghaffari K, Hashemi M, Ebrahimi E and
Shirkoohi R: BIRC5 genomic copy number variation in early-onset
breast cancer. Iran Biomed J. 20:241–245. 2016.PubMed/NCBI
|
|
47
|
Hamy AS, Bieche I, Lehmannche-Che J, Scott
V, Bertheau P, Guinebretière JM, Matthieu MC, Sigal-Zafrani B,
Tembo O, Marty M, et al: BIRC5 (survivin): A pejorative prognostic
marker in stage II/III breast cancer with no response to
neoadjuvant chemotherapy. Breast Cancer Res Treat. 159:499–511.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ding K, Li W, Zou Z, Zou X and Wang C:
CCNB1 is a prognostic biomarker for ER+ breast cancer. Med
Hypotheses. 83:359–364. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Li Y, Chen YL, Xie YT, Zheng LY, Han JY,
Wang H, Tian XX and Fang WG: Association study of germline variants
in CCNB1 and CDK1 with breast cancer susceptibility, progression,
and survival among chinese han women. PLoS One. 8:e844892013.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Shubbar E, Kovács A, Hajizadeh S, Parris
TZ, Nemes S, Gunnarsdóttir K, Einbeigi Z, Karlsson P and Helou K:
Elevated cyclin B2 expression in invasive breast carcinoma is
associated with unfavorable clinical outcome. BMC Cancer. 13:12013.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chang LF, Zhang Z, Yang J, Mclaughlin SH
and Barford D: Molecular architecture and mechanism of the
anaphase-promoting complex. Nature. 513:388–393. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Sewart K and Hauf S: Different
functionality of Cdc20 binding sites within the mitotic checkpoint
complex. Curr Biol. 27:1213–1220. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Wang L, Zhang J, Wan L, Zhou X, Wang Z and
Wei W: Targeting Cdc20 as a novel cancer therapeutic strategy.
Pharmacol Ther. 151:141–151. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Karra H, Repo H, Ahonen I, Löyttyniemi E,
Pitkänen R, Lintunen M, Kuopio T, Söderström M and Kronqvist P:
Cdc20 and securin overexpression predict short-term breast cancer
survival. Br J Cancer. 110:2905–2913. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Endo H, Ikeda K, Urano T, Horie-Inoue K
and Inoue S: Terf/TRIM17 stimulates degradation of kinetochore
protein ZWINT and regulates cell proliferation. J Biochem.
151:139–144. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Lokody I: Signalling: FOXM1 and CENPF:
Co-pilots driving prostate cancer. Nat Rev Cancer. 14:450–451.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Aytes A, Mitrofanova A, Lefebvre C,
Alvarez MJ, Castillo-Martin M, Zheng T, Eastham JA, Gopalan A,
Pienta KJ, Shen MM, et al: Cross-species regulatory network
analysis identifies a synergistic interaction between FOXM1 and
CENPF that drives prostate cancer malignancy. Cancer Res.
25:638–651. 2014.
|
|
58
|
Mollinari C, Kleman JP, Jiang W, Schoehn
G, Hunter T and Margolis RL: PRC1 is a microtubule binding and
bundling protein essential to maintain the mitotic spindle midzone.
J Cell Biol. 157:1175–1186. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Li C, Lin M and Liu J: Identification of
PRC1 as the p53 target gene uncovers a novel function of p53 in the
regulation of cytokinesis. Oncogene. 23:9336–9347. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Nalepa G, Barnholtzsloan J, Enzor R, Dey
D, He Y, Gehlhausen JR, Lehmann AS, Park SJ, Yang Y, Yang X, et al:
The tumor suppressor CDKN3 controls mitosis. J Cell Biol.
201:997–1012. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Fan C, Chen L, Huang Q, Shen T, Welsh EA,
Teer JK, Cai J, Cress WD and Wu J: Overexpression of majorCDKN3
transcripts is associated with poor survival in lung
adenocarcinoma. Br J Cancer. 113:1735–1743. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Berumen J, Espinosa AM and Medina I:
Targeting CDKN3 in cervical cancer. Expert Opin Ther Targets.
18:1149–1162. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Wittmann T, Wilm M, Karsenti E and Vernos
I: Tpx2, a novel xenopus map involved in spindle pole organization.
J Cell Biol. 149:1405–1418. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Yang Y, Li DP, Shen N, Yu XC, Li JB, Song
Q and Zhang JH: TPX2 promotes migration and invasion of human
breast cancer cells. Asian Pac J Trop Med. 8:1064–1070. 2015.
View Article : Google Scholar : PubMed/NCBI
|
